Publications by authors named "Alison J Moskowitz"

Claim this Profile
S
Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World Cohort.
Rachel E Christensen, Robert Stuver, Stephen Dusza, Zachary D Epstein-Peterson, Paola Ghione, Alison J Moskowitz

Clin Lymphoma Myeloma Leuk· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.
Joseph M Rocco, Joseph H Oved, Rikita J Patel, A Zara Herskovits, Namitha Nair, Alison J Moskowitz

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma.
Sanjal H Desai, Alison J Moskowitz, Reid W Merryman, Harsh R Shah, Levi D Pederson

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fit, unfit, or frail? Now easier to tell for Hodgkin lymphoma.
Alison J Moskowitz

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma.
Niloufer Khan, Parastoo B Dahi, Farhad Khimani, Andrei R Shustov, Mazyar Shadman, Alison J Moskowitz

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome.
Amrita Goyal, Daniel O'Leary, Bouthaina Dabaja, Wen-Kai Weng, Jasmine Zain, Alison J Moskowitz

J Am Acad Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era.
Giulio Cassanello, Esther Drill, Annie Qiu, Mark D Ewalt, Paul Hamlin, Alison J Moskowitz

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis.
Efrat Luttwak, Edith Tama Robin, Esther Drill, Alexander Boardman, Philip Caron, Craig H Moskowitz, Alison J Moskowitz

Leuk Lymphoma· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T-Cell Lymphoma: A Real-World Single-Center Experience.
Viviane Liao, Leore Lavin, Michael M Ong, Melissa P Pulitzer, Alison J Moskowitz

J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.
Pallawi Torka, Tatyana Feldman, Kerry J Savage, Nivetha Ganesan, Esther Drill, Alison J Moskowitz

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes.
Robert Stuver, Stephen Dusza, Zachary D Epstein-Peterson, Paola Ghione, Steven M Horwitz, Alison J Moskowitz

J Eur Acad Dermatol Venereol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polytypic B cells, monotypic/monoclonal B-cell proliferations, and neoplastic T cells diverge from -/-mutant clonal hematopoiesis in follicular helper T-cell lymphomas.
Natasha E Lewis, Kseniya Petrova-Drus, Rohan Sardana, Sarah Huet, Qi Gao, Alison J Moskowitz

Haematologica· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.
Amrita Goyal, Daniel O'Leary, Bouthaina Dabaja, Wen-Kai Weng, Jasmine Zain, Alison J Moskowitz

Transplant Cell Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs).
Alison J Moskowitz, Robert N Stuver, Steven M Horwitz

Blood· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis.
William T Johnson, Zachary D Epstein-Peterson, Nivetha Ganesan, Timothy Pak, Tiffany Chang, Alison J Moskowitz

Haematologica· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the best salvage therapy for Hodgkin lymphoma?
Efrat Luttwak, Alison J Moskowitz

Curr Opin Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination chemotherapy for Hodgkin lymphoma.
Alison J Moskowitz

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation.
Zachary D Epstein-Peterson, Esther Drill, Umut Aypar, Connie Lee Batlevi, Philip Caron, Alison J Moskowitz, Craig H Moskowitz

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis.
Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Zinzani, Ann S LaCasce, Craig H Moskowitz, Alison J Moskowitz

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.
Robert Stuver, Agrima Mian, Samantha Brown, Sean Devlin, Paolo F Caimi, Alison J Moskowitz

Am J Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel JAK2 Fusion in T-Cell Prolymphocytic Leukemia.
Ozgur Can Eren, Robert Stuver, Ting Zhou, Michael Zaidinski, Alison J Moskowitz

Genes Chromosomes Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP.
Kurt S Bantilan, Alexandra N Smith, Matthew J Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, Craig H Moskowitz

Blood Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma.
Pier Luigi Zinzani, Gilles Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta

Blood Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma.
Robert Stuver, Ariela Noy, Santosha A Vardhana, Andrew D Zelenetz, Alison J Moskowitz

Br J Haematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma.
Julia Driessen, Gerben J C Zwezerijnen, Heiko Schöder, Marie José Kersten, Alison J Moskowitz, Craig H Moskowitz

Blood Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis